Convergent Science

iq-research-new.jpg

IQ has targeted short-term goals that support a broad long-term vision. Our integrated transdisciplinary initiative of convergent science is designed to bridge the gaps between engineering, medicine and science to advance biomedicine in creative ways that fundamentally change the way healthcare is delivered. In this spirit, IQ has faculty from 15 different departments representing six different colleges who work collaboratively to advance knowledge and develop new technologies. 

The research program incorporates biocomputation, bioengineering, nanomedicine, structural biology, neurodevelopment and neuroscience to define and address visionary large-scale projects such as the Virtual Fetus, the MSU 10-Million Genome project, and The Molecular Persona.

It integrates research with strong and emerging clinical initiatives such as synthetic mammalian biology and Ob/Gyn, chemical biology and pharmacology, molecular imaging and radiology, developmental and stem cell biology and pediatrics/neurodevelopment, biomechanics and musculoskeletal biology and orthopedics, and the Facility for Rare Isotope Beams and nuclear medicine.

To achieve our vision, we rely on strong partnerships and entrepreneurial programs not only at MSU but nationally.


Partnerships

IQ serves as a hub of biomedical innovation that not only impacts MSU, but the local region, the state, and the country. We partner with different entities and organizations to achieve our mission through such ways as corporate sponsorship, entrepreneurship opportunities, philanthropic support and more.

Financial support for IQ will be used to propel innovation using new technologies for scientific discovery including instruments such as MRI, PET, cryoEM, CtTof and MassSpec devices. It will also fund competitive seed grants that spur innovation in precision health and endow training programs and faculty positions.

These partnerships include:

Colleges: Human Medicine; Engineering; Natural Sciences; Veterinary Medicine; Nursing; Osteopathic Medicine; Communication Arts and Sciences; Law; and Business. 

Departments: Pharmacology and Toxicology; Radiology; Pediatrics and Human Development; Microbiology and Molecular Genetics; Physiology; Biochemistry and Molecular Biology; Obstetrics, Gynecology, and Reproductive Biology; Epidemiology and Biostatistics; Translational Science and Molecular Medicine.

Corporate Partners:  PerkinElmer


Entrepreneurship Program

IQ is partnering with the Eli Broad College of Business and the Eli Broad Graduate School of Management on the design of a robust biomedical entrepreneurship program. Through this program, we will drive corporate development through new startup companies and new technologies, leading to new opportunities for our graduates and new innovations for our patients. We also will be using our entrepreneurship resources for the commercialization of MSU innovations.


Zoobiquity Program

We will partner with the MSU’s College of Veterinary Medicine on a species-spanning approach to scientific research that draws expertise from both veterinary and human medicine.


Molecular Imaging Program

IQ will expand the research scope of using non-invasive imaging to help study living processes in the body to build on the foundation of developing and using imaging tools to understand biology. We aim to reveal and resolve the molecular basis of disease. 


Virtual Fetus Program

To truly study life, we need life to study, but real subjects are not always available. This project will draw people from all of IQ’s research themes together to create the virtual fetus, an in silico model of human development. In silico medicine is characterized by modeling, simulation, and visualization of biological and medical processes in computers with the goal of simulating real biological processes in a virtual environment.


MSU 10-Million Genome Program

Michigan has a population of nearly 10 million people. IQ plans to lead a visionary, large-scale project to sequence and analyze all 10 million genomes in the state.


Molecular Persona Program

The Molecular Persona project is aimed at discovering the earliest determinants of behavior and personality.